Corton Capital Inc. Makes New $251,000 Investment in Option Care Health, Inc. (NASDAQ:OPCH)

Corton Capital Inc. bought a new stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 10,806 shares of the company's stock, valued at approximately $251,000.

Several other hedge funds and other institutional investors also recently modified their holdings of OPCH. Barclays PLC boosted its stake in Option Care Health by 180.1% during the 3rd quarter. Barclays PLC now owns 310,194 shares of the company's stock valued at $9,708,000 after purchasing an additional 199,454 shares during the period. Nordea Investment Management AB boosted its position in shares of Option Care Health by 6.0% during the fourth quarter. Nordea Investment Management AB now owns 94,641 shares of the company's stock worth $2,165,000 after buying an additional 5,365 shares during the period. Harbor Capital Advisors Inc. grew its holdings in Option Care Health by 2.7% in the 4th quarter. Harbor Capital Advisors Inc. now owns 213,155 shares of the company's stock worth $4,945,000 after buying an additional 5,595 shares in the last quarter. Graypoint LLC acquired a new stake in Option Care Health in the 4th quarter valued at approximately $1,161,000. Finally, Assenagon Asset Management S.A. raised its stake in Option Care Health by 128.2% during the 4th quarter. Assenagon Asset Management S.A. now owns 292,090 shares of the company's stock valued at $6,776,000 after acquiring an additional 164,086 shares in the last quarter. Institutional investors and hedge funds own 98.05% of the company's stock.

Option Care Health Trading Up 2.1 %

NASDAQ OPCH opened at $33.44 on Thursday. The firm's 50 day moving average price is $33.33 and its two-hundred day moving average price is $28.88. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $35.53. The stock has a market cap of $5.48 billion, a price-to-earnings ratio of 28.10, a PEG ratio of 2.30 and a beta of 0.76.

Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.04. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The firm had revenue of $1.33 billion for the quarter, compared to analyst estimates of $1.26 billion. During the same period in the previous year, the firm earned $0.26 earnings per share. Option Care Health's quarterly revenue was up 16.3% on a year-over-year basis. Equities analysts anticipate that Option Care Health, Inc. will post 1.22 EPS for the current year.

Insider Buying and Selling

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the sale, the insider now owns 44,974 shares in the company, valued at $1,495,835.24. This represents a 40.80 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.64% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on OPCH shares. Jefferies Financial Group upgraded shares of Option Care Health from a "hold" rating to a "buy" rating and lifted their price objective for the company from $26.00 to $35.00 in a research note on Thursday, January 23rd. UBS Group upgraded Option Care Health from a "neutral" rating to a "buy" rating and upped their price objective for the company from $38.00 to $40.00 in a report on Wednesday, April 30th. Barrington Research reaffirmed an "outperform" rating and set a $38.00 target price on shares of Option Care Health in a report on Wednesday, April 30th. JPMorgan Chase & Co. upped their price target on shares of Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a report on Thursday, March 6th. Finally, JMP Securities reaffirmed a "market outperform" rating and issued a $36.00 price objective on shares of Option Care Health in a research note on Tuesday, April 22nd. One analyst has rated the stock with a hold rating and seven have given a buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $35.50.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.